Lornoxicam 4mg Tablet Franchise in Ahmedabad

Anti-Inflammatory Therapy Supplier in Mumbai

Loxifrit 4 Tablet Distributor in Delhi

Pain Management Tablet Franchise Opportunity in Bangalore

Arthritis & Musculoskeletal Tablet Stockist in Hyderabad
Lornoxicam 4mg Export & Manufacturing in Chandigarh

Home/Products /lornoxicam-4mg-tablet

Loxifrit 4 Tablet

Composition : Lornoxicam (4mg) Tablet

Dosage Form : Tablet

Packaging Type : Alu Alu

Packaging : 10*10

Price : ₹1/-

Loxifrit 4 Tablet contains Lornoxicam 4mg, a potent non-steroidal anti-inflammatory drug (NSAID) indicated for the management of pain and inflammation associated with osteoarthritis, rheumatoid arthritis, and musculoskeletal disorders. It helps in relieving joint stiffness, swelling, and discomfort.

Lornoxicam works by inhibiting cyclooxygenase (COX-1 and COX-2) enzymes, reducing the production of prostaglandins responsible for pain, inflammation, and fever. This mechanism ensures rapid relief and improved mobility in affected patients.

For distributors and healthcare suppliers, Loxifrit 4 Tablet is a high-demand analgesic and anti-inflammatory product, commonly prescribed by orthopedists, rheumatologists, and general physicians. The widespread prevalence of arthritis and musculoskeletal pain ensures consistent clinical demand.

Adding Loxifrit 4 Tablet to your pain management and anti-inflammatory therapy segment creates strong opportunities in pharmacies, hospitals, orthopedic clinics, export markets, and third-party manufacturing. Its proven clinical efficacy, broad therapeutic application, and strong prescriber acceptance make it a valuable addition to pharmaceutical distribution portfolios.

Read More

About the Product

Loxifrit 4 Tablet contains Lornoxicam 4mg, a potent non-steroidal anti-inflammatory drug (NSAID) indicated for the management of pain and inflammation associated with osteoarthritis, rheumatoid arthritis, and musculoskeletal disorders. It helps in relieving joint stiffness, swelling, and discomfort.

Lornoxicam works by inhibiting cyclooxygenase (COX-1 and COX-2) enzymes, reducing the production of prostaglandins responsible for pain, inflammation, and fever. This mechanism ensures rapid relief and improved mobility in affected patients.

For distributors and healthcare suppliers, Loxifrit 4 Tablet is a high-demand analgesic and anti-inflammatory product, commonly prescribed by orthopedists, rheumatologists, and general physicians. The widespread prevalence of arthritis and musculoskeletal pain ensures consistent clinical demand.

Adding Loxifrit 4 Tablet to your pain management and anti-inflammatory therapy segment creates strong opportunities in pharmacies, hospitals, orthopedic clinics, export markets, and third-party manufacturing. Its proven clinical efficacy, broad therapeutic application, and strong prescriber acceptance make it a valuable addition to pharmaceutical distribution portfolios.

Common side effects may include nausea, vomiting, stomach pain, dizziness, or headache. Rare but serious side effects include gastrointestinal bleeding, ulcers, liver or kidney dysfunction, and allergic reactions. Patients should seek immediate medical attention if severe or persistent symptoms occur.

Loxifrit 4 Tablet is indicated for the management of acute and chronic pain, inflammation, and fever. It is commonly used in conditions such as osteoarthritis, rheumatoid arthritis, ankylosing spondylitis, postoperative pain, and musculoskeletal injuries.

Before taking Loxifrit 4 Tablet, inform your doctor if you have a history of gastrointestinal disorders, heart disease, kidney or liver problems, or allergy to NSAIDs. The medicine should be used at the prescribed dose for the recommended duration. Avoid combining it with other NSAIDs unless advised by a healthcare professional.

Store Loxifrit 4 Tablet in a cool, dry place, away from direct sunlight and moisture. Keep out of reach of children and ensure the container is properly closed. Do not use the tablet beyond the expiry date.

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Strategic Advisory

Ms. Shiwani Dhiman

VP-Strategic Outreach & Engagement

Ms. Shiwani specializes in market outreach and strategic partnership orchestration for entrepreneurs building scalable PCD Pharma Franchise models.

View Professional Profile

Start Your Journey

Partner With Cafoli

Ready to Dominate your territory with a Monopoly-Based PCD Franchise? Join our rapidly growing network of successful franchise partners and turn your ambitions into reality. Limited Territories Available — Don’t Miss Out!

Quick Navigation